Ultrasound Guided Pes Anserine Bursitis Injection Choices; Prolotherapy or Oxygen-Ozone or Corticosteroid: A Randomized Multicenter Clinical Trial

Author:

Babaei-Ghazani ArashORCID,Eftekharsadat BinaORCID,Soleymanzadeh HosniehORCID,ZoghAli MasoumehORCID

Abstract

Abstract Objective Pes anserine bursitis (PAB) is the most common cause of periarticular knee pain. The aim of the study was to evaluate the efficacy of local injection-based therapies with different materials. Design The enrolled patients were randomly allocated to three groups to receive different interventions. Outcome measures included pain severity using the visual analog scale (VAS) and the Western Ontario McMaster Universities osteoarthritis index (WOMAC) that was evaluated before the intervention, one and eight weeks after that. Results This trial was performed on 72 participants, with male to female ratio of 0.14 and with a mean age of 61.49 ± 9.35 years old. In the first group, corticosteroids in the second group, oxygen–ozone (O2–O3), and in the third group, dextrose 20% was injected into the pes anserine bursa under ultrasound guidance. Interaction between time and group showed a statistically significant improvement in VAS and WOMAC (P ≤ 0.05) in favor of corticosteroids and O2–O3 groups after one week and in favor of O2–O3 and prolotherapy groups after eight weeks. Conclusion All three treatment options are effective for patients with PAB. This study showed that the effects of O2–O3 injection and prolotherapy last longer than those of corticosteroid injection.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Rehabilitation,Physical Therapy, Sports Therapy and Rehabilitation

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3